Back
Phase 2 Participating
Organisations
Following the successes of the first phase of the IMMP the Department of Health agreed to support a second phase. This is currently enabling the spread and roll-out of some of the learning from IMMP phase 1 to 22 more organisations, through the continuing engagement of the existing 25 IMMP sites.
Each team shares the same overall goal and aims and will monitor their progress towards them through the monthly collection and submission of data for a set of ‘global’ programme measures. However, individual teams will be able to plan their own flexible journey through the programme to ensure that this matches their own learning priorities.
Measure 1:
Supporting high quality, cost effective prescribing
An improvement from baseline in one or more of the NHS “Better Care, Better Value” prescribing indicators
Notes:
- Organisations should select the indicator(s) they wish to work towards from the list of NHS “Better Care, Better Value” prescribing indicators
- Further information on the list of indicators will be made available as soon possible
Measure 2:
Reducing re-admissions to hospital due to problems with medicines
The percentage of patients with a confirmed heart failure diagnosis who have been re-admitted to hospital within two months of their last discharge date
Notes:
- A reduction will be interpreted as an improvement
- Any organisation wishing to work on reducing re-admission rates for a different long-term condition should consult with the Medicines Management team before data collection starts
Measure 3:
Increasing the incidence of face-to-face medication review
The percentage of patients with a diagnosed long term condition who have had a documented face-to-face review of their medicines within the last six months
Notes:
- An increase will be interpreted as an improvement
- ‘Face-to-face’ review of medicines implies a two-way discussion between the patient and their health care professional and includes the following processes:
- Medication review undertaken in primary care
- Medicines usage reviews (MUR)
- Medication review undertaken in secondary care
- Domiciliary medication reviews
Measure 4:
Reducing the risk of medication errors at interfaces of care
The percentage of patients with a diagnosed long term condition whose medicines can be fully reconciled at a specific point of care interface
Notes:
- An increase will be interpreted as an improvement
- ‘Medicines Reconciliation’ is the term given to the process of identifying the most recent list of a patient’s current medicines – including the name, dosage, frequency, and route – and comparing them to the current list you are working from in order to establish a complete and accurate list.
- ‘Transfer of Care’ points include
- Discharge from Secondary Care to Primary Care, Community Care, or Care Home
- Admission from Primary Care, Community Care, or Care Home to Secondary Care
- Transfer from ward/unit to ward/unit within a Hospital Trust
- Transfer from one Hospital to another
Measure 5:
Working together across boundaries
The percentage of patients with a diagnosed LTC whose care is managed through locally agreed shared care guidelines
Notes:
- An increase will be interpreted as an improvement
- Organisations will focus one medicine used for a specific LTC
- Where local shared care guidelines do not currently exist organisation may work towards developing such guidelines with their partner organisations
Measure 6:
Reducing waste and increasing efficiency
For Primary Care:
The percentage of patients with a diagnosed long term condition whose repeat medicines are managed through a repeat dispensing scheme
Notes:
- An increase will be interpreted as an improvement
For Secondary Care:
The percentage of ‘PODs’ that are brought in by patients with a diagnosed LTC which are then re-used throughout their stay to discharge
Notes:
- An increase will be interpreted as an improvement
- ‘PODS’ refers to ‘Patient’s Own Drugs’
Back
|
